Core expertise of TOKYO ACTi resides in establishing, enforcing and invalidating intellectual property in the field of pharmaceutical and biotechnology. Because our mission is to be the most trusted and most valued patent law firm in Japan to serve clients in the field of pharmaceutical and biotech industry, we strongly focus on the particular technology area as represented below.
- Pharmaceuticals (small molecules and biologics)
- NCEs (new chemical entities)
- Medical Use
- Dosage Regimen
- Regenerative Medicines
- Therapeutic Proteins
- Therapeutic Antibodies
- Therapeutic RNAi
- Diagnostic Agents
- Medical Devices
- Chemical Products
Roughly, 45 % of our cases are Pharmaceuticals (in a broad term), and 40 % are other Biotechnology, 10 % are Medical Devices.
Currently, half of our work is spent for establishing intellectual property including filing and prosecution. The rest of half is spent for work relating to enforcing and invalidating intellectual property, such as infringement litigation, invalidity litigation, JPO trials, FTO opinion, Validity and Patentability opinion, search, and consulting. This unique balance has repeatedly made it possible to provide best in class services for our clients.
We have successfully obtained many patents that contain commercial products, future products in clinical trial phase, or candidates. Some of them are transferred from other patent law firms after facing difficulties in prosecution. We have also successfully conducted invalidation trials in order to obtain FTO or to achieve other missions.